Unlock Additional 340B Savings with a Data-Driven Analysis

You'll receive two 340B analytics reports, similar to the ones shown above. The first indicates the pharmacies to add/remove based on their net-savings potential.

The second reveals the optimal pharmacy, on a manufacturer by manufacture level, to select as the 'sole-contract' pharmacy on 340B ESP. Additionally, we will share the incremental net-savings your CE can unlock by submitting data to 340B ESP, if you are not already doing so.

We understand that speed is a priority, especially when trying to make Contract Pharmacy designations in time for the HRSA window. Once SolisRx receives the order report, we will deliver the final analysis to you in 2 weeks or less.

Yes, even though you have an in-house pharmacy, 30-70% of your prescription volume is likely going to pharmacies other than your in-house pharmacy. This means that there is still major 340B savings to be captured by optimizing your 340B Contract Pharmacy network.

Yes, even though manufacturer restrictions and 340B ESP have made it more difficult to realize savings from your CP network, by taking a data driven approach, you can still unlock 5-6 figures in incremental net-savings. Additionally, many states are introducing bills that will limit manufacturers' ability to block Contract Pharmacy arrangements, which will make a CP optimization even more valuable.

We've found that even the best managed 340B programs typically have additional value to be captured through a data-driven analysis. We typically identify 5-6 figures in incremental net-savings for most CHCs, FQHCs, SCHs, and smaller DSH 340B Covered Entities. We're so confident in our approach that if we do not identify at least $750 in incremental net-savings for you, we will refund your entire purchase.

Yes! Our team has decades of experience in 340B, and looks forward to helping you understand and interpret the output of the analysis. As part of the analysis, we include a 30 minute session read-out where we walk through the results, answer any questions, and help you craft the next steps with your CPs, TPAs, and HRSA.

We will need a .csv or .xlsx of all prescription orders entered into your EHR in the last 12 months. Each row of the file should represent a given prescription order, and should contain the following columns (note, we do not need any patient information or PHI):
‍
1) Date of Service
2) Prescriber NPI
3) Pharmacy Name and Address
4) NDC-11
5) Rx Quantity
6) Refill Count
7) Primary Insurer

We've found that most EHRs have report generation tools to allow non-technical users to generate a report of historical prescription orders. Typically it only takes a few minutes. That said, if you do need assistance, we can have a call with you and your IT team to define the requirements and guide your team through the report generation process.

Once you have purchased the analysis, we will send you a link to a secure portal where you can upload the file.

Yes, SolisRx leverages technology from Microsoft to ensure our systems are secure. Additionally, we will not be selling your data or sharing it with other parties without your permission.

To conduct this analysis, we do not need any PHI. If we did move forward with a broader engagement, our technologies and processes are HIPAA compliant, and as part of our onboarding, we would execute a BAA between SolisRx and your CE.

If you have additional questions or concerns, feel free to submit them in the contact form below. We'll reach out shortly with answers to your questions and are happy to setup a call to discuss this analysis or any of your 340B questions in more detail.